CLINICAL_TRIALS
trial_result
· 2019-09-06
Clinical Trial Update: Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus [Phase 4]
Summary
Phase 4 post-marketing trial update for KAD-1229 in type 2 diabetes mellitus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2019-09-06